All Sauce from Weekly Sauce:

Yet another study is supporting the notion that the blockbuster GLP-1 drug Ozempic can help problems drinkers curb their intake. The research found that, compared to placebo, weekly injections of semaglutide (also marketed for weight loss as Wegovy) helped reduce cravings in people with alcohol use disorders. The drug also seemed to reduce the quantity…  read on >  read on >

Too often, ADHD and autism coincide in children. New research finds that for many of those kids, this dual diagnosis continues into adult life. Having attention deficit hyperactivity disorder (ADHD) alongside an autism diagnosis was also linked to worse health outcomes overall for adults, the study found. “Generally speaking, rates of ADHD decrease as children grow…  read on >  read on >

As closures of rural hospitals across the United States continue, more Americans are facing hour-plus drives to reach surgical centers, two new reports find. By 2020, data show, 99 million Americans already had trouble finding “timely, high-quality and affordable surgical care,” according to a news release from the University of Michigan.  The situation is most…  read on >  read on >

The tragic early death of “Friends” star Matthew Perry from a ketamine overdose in 2023 has swung a spotlight on the dangers of unsupervised use of the potent anesthetic.  Now, America’s leading group representing anesthesiologists is issuing new guidelines on proper use of the drug.  Ketamine has also come under increasing scrutiny as a treatment…  read on >  read on >

Even if a teen is at a healthy weight, just thinking they are overweight can greatly raise their odds for self-harm, a new study finds. “What we found was that the perception of being overweight has a much stronger effect of suicidal ideation than the objective measure of weight,” said study lead author Philip Baiden.…  read on >  read on >